IOL Chemicals and Pharmaceuticals Ltd. - Research Center
524164 IOLCP Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 2,217.11 | 2,184.02 | 1,966.98 | 1,894.47 | 1,685.33 |
| Operating profit | 226.52 | 256.28 | 591.84 | 573.88 | 409.65 |
| Interest | 16.47 | 8.29 | 5.83 | 20.93 | 51.42 |
| Gross profit | 235.62 | 280.03 | 610.31 | 568.97 | 368.60 |
| EPS (Rs) | 23.84 | 28.22 | 75.72 | 63.51 | 41.61 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 25.57 | 32.04 | 24.30 | 16.02 | 10.37 |
| Stock adjustment | -18.20 | -52.30 | -17.11 | 20.96 | 51.31 |
| Raw material | 1,536.07 | 1,578.91 | 1,119.95 | 1,044.05 | 987.00 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 168.21 | 141.30 | 115.55 | 97.20 | 78.43 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 304.51 | 259.83 | 156.75 | 158.38 | 158.94 |
| Provisions made | - | - | - | - | - |
| Depreciation | 46.13 | 43.26 | 38.92 | 35.73 | 32.45 |
| Taxation | 49.51 | 57.18 | 126.83 | 171.95 | 99.45 |
| Net profit / loss | 139.98 | 165.66 | 444.56 | 361.29 | 236.70 |
| Extra ordinary item | - | -13.93 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 58.71 | 58.71 | 58.71 | 56.89 | 56.89 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 10.22 | 11.73 | 30.09 | 30.29 | 24.31 |
| GPM (%) | 10.51 | 12.64 | 30.65 | 29.78 | 21.74 |
| NPM (%) | 6.24 | 7.48 | 22.33 | 18.91 | 13.96 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis